AR060506A1 - Compuestos organicos - Google Patents
Compuestos organicosInfo
- Publication number
- AR060506A1 AR060506A1 ARP070101533A ARP070101533A AR060506A1 AR 060506 A1 AR060506 A1 AR 060506A1 AR P070101533 A ARP070101533 A AR P070101533A AR P070101533 A ARP070101533 A AR P070101533A AR 060506 A1 AR060506 A1 AR 060506A1
- Authority
- AR
- Argentina
- Prior art keywords
- carbon atoms
- alkyl
- formula
- halogen
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Reivindicacion 1: Un proceso para la preparacion de compuestos de la Formula (1) o un solvato o hidrato de los mismos, en donde: R es fenilo que está insustituido o que está sustituido por 1, 2, o 3 sustituyentes seleccionados a partir del grupo que consiste en halogeno, alquilo de 1 a 7 átomos de carbono, trifluoro-metilo, hidroxilo, y alcoxilo de 1 a 7 átomos de carbono; R1 es hidrogeno o alquilo de 1 a 7 átomos de carbono; R2 es hidrogeno, alquilo de 1 a 7 átomos de carbono, o fenilo que está insustituido o que está sustituido por 1, 2, o 3 sustituyentes seleccionados a partir del grupo que consiste en halogeno, alquilo de 1 a 7 átomos de carbono, trifluoro-metilo, hidroxilo, y alcoxilo de 1 a 7 átomos de carbono; R3 es fenilo que está insustituido o que está sustituido por 1, 2, o 3 sustituyentes seleccionados a partir del grupo que consiste en halogeno, alquilo de 1 a 7 átomos de carbono, trifluoro-metilo, hidroxilo, y alcoxilo de 1 a 7 átomos de carbono, o r3 es nftilo, 1H- indol-3-ilo, o 1-alquilo de 1 a 7 átomos de carbono-indol-3-ilo, y R5 eds cicloalquilo de 3 a 8 átomos de carbono, D-azacicloheptan-2-on-3-ilo o L-aza-cicloheptan-2-on-3-ilo, comprendiendo el proceso los pasos de: (a) Hacer reaccionar un compuesto de la Formula (2) en donde R1, R2, R3, y R5 son como se definen en esta reivindicacion anteriormente, y T es un grupo protector, con una base, para formar un compuesto de la Formula (3); en donde R1, R2, R3, R5 son como se definen en esta reivindicacion anteriormente; y (b) hacer reaccionar un compuesto de la Formula ll. como R1, R2, R3, y R5 son como se definen en esta reivindicacion anteriormente, con un compuesto de la Formula (4) por 1, 2, o 3 sustituyentes seleccionados a partir del grupo que consiste en halogeno, alquilon de 1 a 7 átomos de carbono, trifluorometilo, hidroxilo y alcoxilo de 1 a 7 átomos de carbono, y X es halogeno, en la presencia de una base, para formar un compuesto de la Formula 1, y c) opcionalmente, formal un solvato o hidrato deseado de los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0607532A GB0607532D0 (en) | 2006-04-13 | 2006-04-13 | Organic compounds |
GB0610244A GB0610244D0 (en) | 2006-05-23 | 2006-05-23 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR060506A1 true AR060506A1 (es) | 2008-06-25 |
Family
ID=38324102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070101533A AR060506A1 (es) | 2006-04-13 | 2007-04-11 | Compuestos organicos |
Country Status (29)
Country | Link |
---|---|
US (2) | US8008479B2 (es) |
EP (1) | EP2010498B1 (es) |
JP (1) | JP5208917B2 (es) |
KR (1) | KR20080108291A (es) |
AR (1) | AR060506A1 (es) |
AT (1) | ATE486853T1 (es) |
AU (1) | AU2007237482B2 (es) |
CA (1) | CA2645362C (es) |
CL (1) | CL2007001040A1 (es) |
CY (1) | CY1111294T1 (es) |
DE (1) | DE602007010269D1 (es) |
DK (1) | DK2010498T3 (es) |
EC (1) | ECSP088820A (es) |
GT (1) | GT200800209A (es) |
HK (1) | HK1125640A1 (es) |
HR (1) | HRP20110045T1 (es) |
JO (1) | JO2630B1 (es) |
MA (1) | MA30394B1 (es) |
MX (1) | MX2008013117A (es) |
MY (1) | MY145069A (es) |
NO (1) | NO20084783L (es) |
NZ (1) | NZ571142A (es) |
PE (1) | PE20071223A1 (es) |
PL (1) | PL2010498T3 (es) |
PT (1) | PT2010498E (es) |
RU (1) | RU2433122C2 (es) |
SI (1) | SI2010498T1 (es) |
TW (1) | TW200815358A (es) |
WO (1) | WO2007118651A1 (es) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0515973B8 (pt) | 2004-10-12 | 2021-07-27 | Fmc Biopolymer As | kit para produzir um gel de alginato, composição para preparar um gel e uso |
BRPI0615973A2 (pt) | 2005-07-29 | 2011-05-31 | Concert Pharmaceuticals Inc | novos derivados de benzo [d] [1,3] - dioxol |
US8796267B2 (en) | 2006-10-23 | 2014-08-05 | Concert Pharmaceuticals, Inc. | Oxazolidinone derivatives and methods of use |
US8071596B2 (en) | 2007-01-12 | 2011-12-06 | Concert Pharmaceuticals, Inc. | Endothelin receptor antagonists |
US8080549B2 (en) | 2007-01-12 | 2011-12-20 | Concert Pharmaceuticals, Inc. | Endothelin receptor antagonists |
US8013007B2 (en) | 2007-02-26 | 2011-09-06 | Concert Pharmaceuticals, Inc. | Alpha 1A-adrenoceptor antagonists |
US7943620B2 (en) | 2007-03-07 | 2011-05-17 | Concert Pharmaceuticals, Inc. | Anti-anginal compounds |
WO2008115442A1 (en) | 2007-03-16 | 2008-09-25 | Concert Pharmceuticals, Inc. | Inhibitors of cholesterol ester transfer protein |
WO2008128166A1 (en) | 2007-04-13 | 2008-10-23 | Concert Pharmaceuticals Inc. | Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds |
US8349817B2 (en) | 2007-04-25 | 2013-01-08 | Concert Pharmaceuticals, Inc. | Analogues of cilostazol |
US20090042842A1 (en) | 2007-04-25 | 2009-02-12 | Concert Pharmaceuticals, Inc. | Analogues of cilostazol |
PL2522668T3 (pl) | 2007-05-01 | 2015-07-31 | Concert Pharmaceuticals Inc | Związki morfinanu |
HUE029782T2 (en) | 2007-05-01 | 2017-04-28 | Concert Pharmaceuticals Inc | morphinan |
US7820666B2 (en) | 2007-05-08 | 2010-10-26 | Concert Pharmaceuticals, Inc. | Tetrahydrotriazolopyrazine derivatives and uses thereof |
WO2008156632A1 (en) | 2007-06-12 | 2008-12-24 | Concert Pharmaceuticals, Inc. | Azapeptide derivatives |
CA2702317A1 (en) | 2007-07-09 | 2009-01-15 | Concert Pharmaceuticals, Inc. | Novel pyrimidinecarboxamide derivatives |
CN101821260B (zh) | 2007-08-14 | 2013-07-31 | 康塞特医药品有限公司 | 取代的噁唑烷酮衍生物 |
AU2008296975B2 (en) | 2007-08-28 | 2014-07-24 | Fmc Corporation | Delayed self-gelling alginate systems and uses thereof |
EP2197847B1 (en) | 2007-09-12 | 2012-11-07 | Concert Pharmaceuticals Inc. | Deuterated 4 -oxoquinoline derivative for the treatment of hiv infection |
CN101855218A (zh) | 2007-09-13 | 2010-10-06 | 康塞特医药品有限公司 | 氘化的儿茶酚和苯并[d][1,3]间二氧杂环戊烯及其衍生物的合成 |
US8410124B2 (en) | 2007-10-18 | 2013-04-02 | Concert Pharmaceuticals Inc. | Deuterated etravirine |
US8592487B2 (en) | 2007-10-26 | 2013-11-26 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
WO2009079637A1 (en) | 2007-12-18 | 2009-06-25 | Concert Pharmaceuticals, Inc. | Tetrahydroisoquinoline derivatives |
US7855204B2 (en) | 2008-01-22 | 2010-12-21 | Concert Pharmaceuticals Inc. | Derivatives of gefitinib |
WO2009094210A1 (en) | 2008-01-22 | 2009-07-30 | Concert Pharmaceuticals Inc. | Vandetanib derivatives |
EP2265334A2 (en) | 2008-02-29 | 2010-12-29 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
US8367674B2 (en) | 2008-04-17 | 2013-02-05 | Concert Pharmaceuticals, Inc. | Piperazine derivatives |
WO2009154754A2 (en) | 2008-06-17 | 2009-12-23 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated morpholine derivatives |
CA2735549A1 (en) | 2008-08-29 | 2010-03-04 | Concert Pharmaceuticals, Inc. | Substituted triazolo-pyridazine derivatives |
EP2334621A1 (en) | 2008-09-16 | 2011-06-22 | Concert Pharmaceuticals, Inc. | Deuterated 2-amino-3-hydroxypropanoic acid derivatives |
DK2418211T3 (en) | 2008-09-19 | 2016-06-27 | Concert Pharmaceuticals Inc | DEUTERATED MORPHINAN COMPOUNDS |
US9045453B2 (en) | 2008-11-14 | 2015-06-02 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
JP5425229B2 (ja) * | 2009-02-24 | 2014-02-26 | ノバルティス アーゲー | Nk受容体アンタゴニストの使用 |
US8263601B2 (en) | 2009-02-27 | 2012-09-11 | Concert Pharmaceuticals, Inc. | Deuterium substituted xanthine derivatives |
DE102009001446A1 (de) | 2009-03-10 | 2010-09-23 | Evonik Rohmax Additives Gmbh | Verwendung von Kammpolymeren als Antifatigue-Additive |
US8563554B2 (en) | 2009-03-17 | 2013-10-22 | Concert Pharmaceuticals, Inc. | Deuterated pyrazinoisoquinoline compounds |
WO2010108103A1 (en) * | 2009-03-19 | 2010-09-23 | Concert Pharmaceuticals, Inc. | Azepan-2-one derivatives |
WO2010124046A1 (en) | 2009-04-23 | 2010-10-28 | Concert Pharmaceuticals, Inc. | 4-hydroxybutyric acid analogs |
WO2010135579A1 (en) | 2009-05-22 | 2010-11-25 | Concert Pharmaceuticals, Inc. | Fluorinated diaryl urea derivatives |
EP2443089B1 (en) | 2009-06-18 | 2014-03-05 | Concert Pharmaceuticals Inc. | Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors |
WO2011005520A1 (en) | 2009-06-23 | 2011-01-13 | Concert Pharmaceuticals, Inc. | Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators |
EP2464355A4 (en) | 2009-08-14 | 2013-01-02 | Concert Pharmaceuticals Inc | SUBSTITUTED TRIAZOLPHTHALAZINE DERIVATIVES |
IN2012DN01642A (es) | 2009-09-02 | 2015-06-05 | Concert Pharmaceuticals Inc | |
WO2011028820A1 (en) | 2009-09-02 | 2011-03-10 | Concert Pharmaceuticals, Inc. | Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds |
US8278460B2 (en) | 2009-10-15 | 2012-10-02 | Concert Pharmaceuticals, Inc. | Substituted benzimidazoles |
US8471034B2 (en) | 2009-11-18 | 2013-06-25 | Concert Pharmaceuticals, Inc. | Niacin prodrugs and deuterated versions thereof |
DE102010001040A1 (de) | 2010-01-20 | 2011-07-21 | Evonik RohMax Additives GmbH, 64293 | (Meth)acrylat-Polymere zur Verbesserung des Viskositätsindexes |
EP2542534A1 (en) | 2010-03-02 | 2013-01-09 | Concert Pharmaceuticals Inc. | Deuterated tetrahydronaphthalene derivatives |
US8575361B2 (en) | 2010-03-02 | 2013-11-05 | Concert Pharmaceuticals Inc. | Tetrahydronaphthalene derivatives |
US9226801B2 (en) * | 2010-03-08 | 2016-01-05 | Ibur, Llc | Custom linkable imaging and multifunctional tray |
WO2011116066A1 (en) | 2010-03-17 | 2011-09-22 | Concert Pharmaceuticals, Inc. | Derivatives of dimethylcurcumin |
WO2012009446A1 (en) | 2010-07-16 | 2012-01-19 | Concert Pharmaceuticals Inc. | Novel pyrimidinecarboxamide derivatives |
WO2012031073A1 (en) | 2010-09-01 | 2012-03-08 | Concert Pharmaceuticals, Inc. | Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
WO2012031072A1 (en) | 2010-09-01 | 2012-03-08 | Concert Pharmaceuticals, Inc. | Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
KR101976218B1 (ko) | 2011-02-14 | 2019-05-07 | 콘서트 파마슈티컬즈, 인크. | 4-히드록시부티르산 중수소화 유사체 |
US9145390B2 (en) | 2011-03-03 | 2015-09-29 | Concert Pharmaceuticals, Inc. | Derivatives of pyrazole-substituted amino-heteroaryl compounds |
US8889687B2 (en) | 2011-03-04 | 2014-11-18 | Concert Pharmaceuticals, Inc. | Deuterated pyrazinoisoquinoline compounds |
HUE047354T2 (hu) | 2011-05-18 | 2020-04-28 | Vertex Pharmaceuticals Europe Ltd | Ivacaftor deuterizált származékai |
CA2869874A1 (en) | 2012-04-13 | 2013-10-17 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
US9249093B2 (en) | 2012-04-20 | 2016-02-02 | Concert Pharmaceuticals, Inc. | Deuterated rigosertib |
US20150197525A1 (en) | 2012-06-15 | 2015-07-16 | Concert Pharmaceuticals, Inc. | Deuterated derivatives of ruxolitinib |
US9181190B2 (en) | 2012-07-04 | 2015-11-10 | Concert Pharmaceuticals, Inc. | Deuterated vercirnon |
CA2908929C (en) | 2012-07-12 | 2021-01-26 | Concert Pharmaceuticals, Inc. | Deuterated idebenone |
AU2013296627C9 (en) | 2012-07-30 | 2018-03-22 | Concert Pharmaceuticals, Inc. | Deuterated ibrutinib |
WO2014028756A1 (en) | 2012-08-17 | 2014-02-20 | Concert Pharmaceuticals, Inc. | Deuterated baricitinib |
JP2015534989A (ja) | 2012-10-22 | 2015-12-07 | コンサート ファーマシューティカルズ インコーポレイテッド | {s−3−(4−アミノ−1−オキソ−イソインドリン−2−イル)(ピペリジン−3,4,4,5,5−d5)−2,6−ジオン}の固体形態 |
ES2672468T3 (es) | 2013-01-09 | 2018-06-14 | Concert Pharmaceuticals Inc. | Momelotinib deuterado |
EP2968268B1 (en) | 2013-03-15 | 2020-07-29 | Concert Pharmaceuticals Inc. | Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase |
US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
US9676790B2 (en) | 2013-08-30 | 2017-06-13 | Concert Pharmaceuticals, Inc. | Substituted thienotriazolodiazapines |
CN106459056A (zh) | 2014-02-10 | 2017-02-22 | 康塞特医药品公司 | 经取代的三唑苯二氮卓 |
US10160778B2 (en) | 2014-10-27 | 2018-12-25 | Concert Pharmaceuticals, Inc. | Pyrimidine phosphonic acid esters |
US10196384B2 (en) | 2015-03-31 | 2019-02-05 | Vertex Pharmaceuticals (Europe) Limited | Deuterated CFTR modulators |
WO2016176335A1 (en) | 2015-04-27 | 2016-11-03 | Concert Pharmaceuticals, Inc. | Deuterated otx-015 |
US10759721B2 (en) | 2015-09-25 | 2020-09-01 | Vertex Pharmaceuticals (Europe) Limited | Deuterated CFTR potentiators |
US11267777B2 (en) | 2015-11-19 | 2022-03-08 | Concert Pharmaceuticals, Inc. | Deuterated EPI-743 |
EP3416629A4 (en) | 2016-02-16 | 2019-08-07 | CoNCERT Pharmaceuticals, Inc. | DEUTERATED GFT-505 |
CA3082834A1 (en) | 2017-11-22 | 2019-05-31 | Concert Pharmaceuticals, Inc. | Deuterated analogs of d-serine and uses thereof |
CA3082444A1 (en) | 2017-12-01 | 2019-06-06 | Vertex Pharmaceuticals Incorporated | Processes for making modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996026183A1 (en) * | 1995-02-22 | 1996-08-29 | Novartis Ag | 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
MY132550A (en) | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
GB0010958D0 (en) | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
-
2007
- 2007-04-10 JO JO2007129A patent/JO2630B1/en active
- 2007-04-11 NZ NZ571142A patent/NZ571142A/en not_active IP Right Cessation
- 2007-04-11 AU AU2007237482A patent/AU2007237482B2/en not_active Ceased
- 2007-04-11 PT PT07724154T patent/PT2010498E/pt unknown
- 2007-04-11 MX MX2008013117A patent/MX2008013117A/es active IP Right Grant
- 2007-04-11 KR KR1020087024839A patent/KR20080108291A/ko not_active Application Discontinuation
- 2007-04-11 AR ARP070101533A patent/AR060506A1/es not_active Application Discontinuation
- 2007-04-11 EP EP07724154A patent/EP2010498B1/en active Active
- 2007-04-11 CA CA2645362A patent/CA2645362C/en not_active Expired - Fee Related
- 2007-04-11 AT AT07724154T patent/ATE486853T1/de active
- 2007-04-11 WO PCT/EP2007/003213 patent/WO2007118651A1/en active Application Filing
- 2007-04-11 RU RU2008145102/04A patent/RU2433122C2/ru not_active IP Right Cessation
- 2007-04-11 DE DE602007010269T patent/DE602007010269D1/de active Active
- 2007-04-11 US US12/296,969 patent/US8008479B2/en not_active Expired - Fee Related
- 2007-04-11 PL PL07724154T patent/PL2010498T3/pl unknown
- 2007-04-11 DK DK07724154.5T patent/DK2010498T3/da active
- 2007-04-11 SI SI200730483T patent/SI2010498T1/sl unknown
- 2007-04-11 JP JP2009504637A patent/JP5208917B2/ja not_active Expired - Fee Related
- 2007-04-11 PE PE2007000444A patent/PE20071223A1/es not_active Application Discontinuation
- 2007-04-12 CL CL200701040A patent/CL2007001040A1/es unknown
- 2007-04-12 TW TW096112886A patent/TW200815358A/zh unknown
-
2008
- 2008-10-08 MY MYPI20083997A patent/MY145069A/en unknown
- 2008-10-10 GT GT200800209A patent/GT200800209A/es unknown
- 2008-10-13 EC EC2008008820A patent/ECSP088820A/es unknown
- 2008-11-03 MA MA31347A patent/MA30394B1/fr unknown
- 2008-11-12 NO NO20084783A patent/NO20084783L/no not_active Application Discontinuation
-
2009
- 2009-05-15 HK HK09104457.9A patent/HK1125640A1/xx not_active IP Right Cessation
-
2011
- 2011-01-21 HR HR20110045T patent/HRP20110045T1/hr unknown
- 2011-01-26 CY CY20111100082T patent/CY1111294T1/el unknown
- 2011-07-22 US US13/188,795 patent/US20110282053A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR060506A1 (es) | Compuestos organicos | |
PE20121047A1 (es) | Derivados de tiazolilpiperidina como fungicidas | |
CY1119101T1 (el) | Ναφθαλινο-ισοξαζολινες ως παραγοντες καταπολεμισης ασπονδυλων παρασιτων | |
BR112013009935B8 (pt) | Compostos | |
PE20130375A1 (es) | Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos | |
BR112012014858A2 (pt) | agente antiplaqueta | |
PE20130155A1 (es) | Derivados de ariletinilo | |
AR072166A1 (es) | Derivado de piperidina y su uso como inhibidor de renina superior | |
AR078163A1 (es) | Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes | |
CU20110052A7 (es) | Compuestos orgánicos | |
PE20121159A1 (es) | DERIVADOS DE PIRIDINA, PIRAZINA Y QUINOLINA COMO INHIBIDORES DE LA FOSFOINOSITIDA 3 CINASA Y LA mTOR | |
CO6362009A2 (es) | Derivados de morfolinopurina | |
PE20140192A1 (es) | Derivados de bencimidazol como inhibidores de cinasa pi3 | |
UY30045A1 (es) | Derivados de pirimidina | |
PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
AR073130A1 (es) | Derivados de 5-bencil-4-azolilmetil-4-espiro [2.4] heptanol, metodos para producir los mismos y agentes agrohorticolas y agentes para proteger material industrial que los contienen. | |
CO6220935A2 (es) | Derivados de 1,2,4-triazol como moduladores de mglur5 | |
AR079316A1 (es) | Derivado de azol, compuestos intermedios para obtenerlo, metodos para producirlos y agente agro- horticola o agente de proteccion de material industrial que lo comprende | |
ES2567311T3 (es) | 6-(3-Aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinas como antagonistas del receptor de ADP | |
AR080596A1 (es) | Compuestos alquilamido y composiciones farmaceuticas | |
BR112013008675A2 (pt) | métodos e composições para o tratamento de diabetes e dislipidemia | |
CR10780A (es) | Inhibidores de cinasa | |
MA32192B1 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
AR062769A1 (es) | Derivados de 5- fenil- nicotilamida | |
AR060962A1 (es) | Proceso de preparacion de derivados de quinazolina e intermediarios de sintesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |